This inventor holds 5 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Gw Research Limited, Jazz Pharmaceuticals Research UK Limited, Other. Active years: 1999-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- West Buckland, Somerset TA21 9LA, GB (1999)
- Cambridge, GB (2021 - 2022)
Company Filing History:
2 out of 49 
2 out of 23 
1 out of 834,570 Years Active: 1999-2026
Title: The Innovative Contributions of David Critchley in Treating Tuberous Sclerosis Complex
Introduction: David Critchley, an inventive mind hailing from Cambridge, GB, has made significant strides in the field of medical innovation. With a total of three patents to his name, he has focused on developing effective treatments for complex health conditions, particularly tuberous sclerosis complex.
Latest Patents: One of Critchley’s most notable inventions involves methods of treating tuberous sclerosis complex utilizing cannabidiol and everolimus. This patent outlines a novel approach to managing the symptoms and complications associated with this condition, showcasing his commitment to improving patient care through innovative therapies.
Career Highlights: Critchley has built an impressive career by contributing to the advancement of medical science. His work with companies like GW Research Limited and Jazz Pharmaceuticals Research UK Limited has positioned him at the forefront of research and development in therapeutic solutions.
Collaborations: Throughout his career, Critchley has collaborated with reputable professionals in the field, including Geoffrey W. Guy and Volker Knappertz. These collaborations have not only enhanced his research efforts but have also fostered an environment for innovative breakthroughs in treatment methodologies.
Conclusion: David Critchley's work exemplifies the spirit of innovation in the medical field. His patents serve as a testament to his dedication and expertise in developing effective treatments for tuberous sclerosis complex. As he continues to pursue advancements in his field, his contributions remain vital in improving the lives of those affected by this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile